We're kicking off the 43rd Annual Healthcare Conference this morning, and I couldn't be more delighted to introduce Vertex's CEO, Reshma Kewalramani. She's going to come on stage to give a ...

CNBC’s Angelica Peebles and Vertex JournavxPharmaceuticals CEO Reshma Kewalramani join 'Squawk on the Street' to discuss the FDA's approval of the company's non-opioid painkiller pill Journavx ...

Vertex Pharmaceuticals’ breakthrough in cystic ... drugs and drug combinations that can treat 90% of CF patients. CEO Reshma Kewalramani says Vertex aims to eventually reach all CF patients.

Vertex Pharmaceuticals' (NASDAQ ... I'm going to start with the company's newest CF therapy, Alyftrek. Vertex CEO Reshma Kewalramani said in the Q1 earnings call that management is "pleased ...